Carcinoembryonic antigen-expressing measles virus (National Cancer Institute)
N/A
Report date: 2023/01/07 17:45:59
Base Information
Drug NameCarcinoembryonic antigen-expressing measles virus (National Cancer Institute)
Drug Alias Name
Classification
Mechanisms of Action
Targets
Therapy Area/Indications +[6]
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/Territory
CombinationsNo
Global Highest StatusPhase 1 Clinical
Highest Status in ChinaN/A
Originator CompaniesNational Cancer Institute
China Registration ClassN/A
Develop Information
Active CompaniesNational Cancer Institute
Inactive CompaniesN/A
Active Indications +[5]
Inactive Indications
Other Information
ATC CodeN/A
Related LinksN/A